Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents

The purpose was to analyze the technical, clinical, and survival outcomes of our patients with malignant superior cava vein syndrome (SVCS) treated with endovascular approach and analyze the efficacy of different stent types used. It is an observational, retrospective, single-center study. From 2006...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of endovascular therapy 2024-04, p.15266028241242926-15266028241242926
Hauptverfasser: Rioja Artal, Sara, González Martínez, Victor, Royo Serrando, Josep, Delgado Daza, Rafael, Moga Donadeu, Lluis
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15266028241242926
container_issue
container_start_page 15266028241242926
container_title Journal of endovascular therapy
container_volume
creator Rioja Artal, Sara
González Martínez, Victor
Royo Serrando, Josep
Delgado Daza, Rafael
Moga Donadeu, Lluis
description The purpose was to analyze the technical, clinical, and survival outcomes of our patients with malignant superior cava vein syndrome (SVCS) treated with endovascular approach and analyze the efficacy of different stent types used. It is an observational, retrospective, single-center study. From 2006 to 2023, 42 patients (32 male, 10 female, mean age 62 years, age range, 41-87 years) underwent percutaneous stent placement for malignant SVCS. One stainless steel stent (Wallstent) and 2 venous nitinol stent type (Sinus-XL, Venovo) were used. Follow-up mean was 276 days. A total of 53 stents were deployed. Clinical success was 97.6% in less 24 hours. Technical success was achieved in 97.6%. No complications were found except 1 patient died during the procedure due to stent migration and atrial dissociation (2.3%). Overall intraprocedural stent migration rate was 11.9% (18.8% stainless steel stent, 9.6% nitinol stent, p>0.05). Overall survival rates were 87.8%, 41.99%, and 34.12%, and overall primary patency rates were 100%, 93.3%, 91.6% at 1, 6, and 12 months, respectively. Endovascular treatment is a safe and effective therapeutic option for SVCS with high technical and clinical success rates and low complication and recurrence rates. The malignant superior cava vein syndrome is a rare clinical entity treated classically with radiation and chemotherapy with a slower response, or surgical bypass, which is an aggressive surgical technique. Endovascular treatment offers a low-invasive technique with quick clinical resolution and good permeability results. However, further studies are lacking to deal with procedure technical characteristics, stent type used, technical complications, and medium- and long-term patency studies. This study aims to evaluate all these items, analysing self-expanding stainless steel and nitinol venous bare metal stents, and add value to endovascular treatment, confirming the good results of this technique.
doi_str_mv 10.1177/15266028241242926
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3047937589</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3047937589</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-bc92723fdfc63597f1af902811971092f22aad3e581b703723b77002419c749f3</originalsourceid><addsrcrecordid>eNplkU1v1DAQhi0Eoh_wA7ggH7mkeOwkjo9lVWilfoltuUazybgy8jqL7VRd_kf_bxO27YWTx9b7PuN5h7FPII4AtP4KlaxrIRtZgiylkfUbtg9VWRVQVeLtXMu6mAV77CCl30JIkADv2Z5qal2Xotlnjz8pjT4nPlh-jd47zO6e-DJTyC7ccRf4BXp3FzBkvhw3FN0Q-S8KyBd4j3y5DX0c1sSPA_rt39myJG-Lk4cNhv7fNaMLnlKaoeT59Mwv3QQf_MwZxsS_YSR-QRn9rnH6wN5Z9Ik-Pp-H7Pb7yc3itDi_-nG2OD4vOiUgF6vOSC2V7W1Xq8poC2jNNC6A0SCMtFIi9oqqBlZaqEm60npKoQTT6dJYdci-7LibOPwZKeV27VJH3mOg6WOtEqU2SleNmaSwk3ZxSCmSbTfRrTFuWxDtvI32v21Mns_P-HG1pv7V8RK_egIn1IVd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3047937589</pqid></control><display><type>article</type><title>Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents</title><source>SAGE Complete A-Z List</source><creator>Rioja Artal, Sara ; González Martínez, Victor ; Royo Serrando, Josep ; Delgado Daza, Rafael ; Moga Donadeu, Lluis</creator><creatorcontrib>Rioja Artal, Sara ; González Martínez, Victor ; Royo Serrando, Josep ; Delgado Daza, Rafael ; Moga Donadeu, Lluis</creatorcontrib><description>The purpose was to analyze the technical, clinical, and survival outcomes of our patients with malignant superior cava vein syndrome (SVCS) treated with endovascular approach and analyze the efficacy of different stent types used. It is an observational, retrospective, single-center study. From 2006 to 2023, 42 patients (32 male, 10 female, mean age 62 years, age range, 41-87 years) underwent percutaneous stent placement for malignant SVCS. One stainless steel stent (Wallstent) and 2 venous nitinol stent type (Sinus-XL, Venovo) were used. Follow-up mean was 276 days. A total of 53 stents were deployed. Clinical success was 97.6% in less 24 hours. Technical success was achieved in 97.6%. No complications were found except 1 patient died during the procedure due to stent migration and atrial dissociation (2.3%). Overall intraprocedural stent migration rate was 11.9% (18.8% stainless steel stent, 9.6% nitinol stent, p&gt;0.05). Overall survival rates were 87.8%, 41.99%, and 34.12%, and overall primary patency rates were 100%, 93.3%, 91.6% at 1, 6, and 12 months, respectively. Endovascular treatment is a safe and effective therapeutic option for SVCS with high technical and clinical success rates and low complication and recurrence rates. The malignant superior cava vein syndrome is a rare clinical entity treated classically with radiation and chemotherapy with a slower response, or surgical bypass, which is an aggressive surgical technique. Endovascular treatment offers a low-invasive technique with quick clinical resolution and good permeability results. However, further studies are lacking to deal with procedure technical characteristics, stent type used, technical complications, and medium- and long-term patency studies. This study aims to evaluate all these items, analysing self-expanding stainless steel and nitinol venous bare metal stents, and add value to endovascular treatment, confirming the good results of this technique.</description><identifier>ISSN: 1526-6028</identifier><identifier>EISSN: 1545-1550</identifier><identifier>DOI: 10.1177/15266028241242926</identifier><identifier>PMID: 38676408</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of endovascular therapy, 2024-04, p.15266028241242926-15266028241242926</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-bc92723fdfc63597f1af902811971092f22aad3e581b703723b77002419c749f3</citedby><cites>FETCH-LOGICAL-c301t-bc92723fdfc63597f1af902811971092f22aad3e581b703723b77002419c749f3</cites><orcidid>0009-0001-0636-6156 ; 0009-0001-1066-122X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38676408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rioja Artal, Sara</creatorcontrib><creatorcontrib>González Martínez, Victor</creatorcontrib><creatorcontrib>Royo Serrando, Josep</creatorcontrib><creatorcontrib>Delgado Daza, Rafael</creatorcontrib><creatorcontrib>Moga Donadeu, Lluis</creatorcontrib><title>Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents</title><title>Journal of endovascular therapy</title><addtitle>J Endovasc Ther</addtitle><description>The purpose was to analyze the technical, clinical, and survival outcomes of our patients with malignant superior cava vein syndrome (SVCS) treated with endovascular approach and analyze the efficacy of different stent types used. It is an observational, retrospective, single-center study. From 2006 to 2023, 42 patients (32 male, 10 female, mean age 62 years, age range, 41-87 years) underwent percutaneous stent placement for malignant SVCS. One stainless steel stent (Wallstent) and 2 venous nitinol stent type (Sinus-XL, Venovo) were used. Follow-up mean was 276 days. A total of 53 stents were deployed. Clinical success was 97.6% in less 24 hours. Technical success was achieved in 97.6%. No complications were found except 1 patient died during the procedure due to stent migration and atrial dissociation (2.3%). Overall intraprocedural stent migration rate was 11.9% (18.8% stainless steel stent, 9.6% nitinol stent, p&gt;0.05). Overall survival rates were 87.8%, 41.99%, and 34.12%, and overall primary patency rates were 100%, 93.3%, 91.6% at 1, 6, and 12 months, respectively. Endovascular treatment is a safe and effective therapeutic option for SVCS with high technical and clinical success rates and low complication and recurrence rates. The malignant superior cava vein syndrome is a rare clinical entity treated classically with radiation and chemotherapy with a slower response, or surgical bypass, which is an aggressive surgical technique. Endovascular treatment offers a low-invasive technique with quick clinical resolution and good permeability results. However, further studies are lacking to deal with procedure technical characteristics, stent type used, technical complications, and medium- and long-term patency studies. This study aims to evaluate all these items, analysing self-expanding stainless steel and nitinol venous bare metal stents, and add value to endovascular treatment, confirming the good results of this technique.</description><issn>1526-6028</issn><issn>1545-1550</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNplkU1v1DAQhi0Eoh_wA7ggH7mkeOwkjo9lVWilfoltuUazybgy8jqL7VRd_kf_bxO27YWTx9b7PuN5h7FPII4AtP4KlaxrIRtZgiylkfUbtg9VWRVQVeLtXMu6mAV77CCl30JIkADv2Z5qal2Xotlnjz8pjT4nPlh-jd47zO6e-DJTyC7ccRf4BXp3FzBkvhw3FN0Q-S8KyBd4j3y5DX0c1sSPA_rt39myJG-Lk4cNhv7fNaMLnlKaoeT59Mwv3QQf_MwZxsS_YSR-QRn9rnH6wN5Z9Ik-Pp-H7Pb7yc3itDi_-nG2OD4vOiUgF6vOSC2V7W1Xq8poC2jNNC6A0SCMtFIi9oqqBlZaqEm60npKoQTT6dJYdci-7LibOPwZKeV27VJH3mOg6WOtEqU2SleNmaSwk3ZxSCmSbTfRrTFuWxDtvI32v21Mns_P-HG1pv7V8RK_egIn1IVd</recordid><startdate>20240427</startdate><enddate>20240427</enddate><creator>Rioja Artal, Sara</creator><creator>González Martínez, Victor</creator><creator>Royo Serrando, Josep</creator><creator>Delgado Daza, Rafael</creator><creator>Moga Donadeu, Lluis</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0001-0636-6156</orcidid><orcidid>https://orcid.org/0009-0001-1066-122X</orcidid></search><sort><creationdate>20240427</creationdate><title>Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents</title><author>Rioja Artal, Sara ; González Martínez, Victor ; Royo Serrando, Josep ; Delgado Daza, Rafael ; Moga Donadeu, Lluis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-bc92723fdfc63597f1af902811971092f22aad3e581b703723b77002419c749f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rioja Artal, Sara</creatorcontrib><creatorcontrib>González Martínez, Victor</creatorcontrib><creatorcontrib>Royo Serrando, Josep</creatorcontrib><creatorcontrib>Delgado Daza, Rafael</creatorcontrib><creatorcontrib>Moga Donadeu, Lluis</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of endovascular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rioja Artal, Sara</au><au>González Martínez, Victor</au><au>Royo Serrando, Josep</au><au>Delgado Daza, Rafael</au><au>Moga Donadeu, Lluis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents</atitle><jtitle>Journal of endovascular therapy</jtitle><addtitle>J Endovasc Ther</addtitle><date>2024-04-27</date><risdate>2024</risdate><spage>15266028241242926</spage><epage>15266028241242926</epage><pages>15266028241242926-15266028241242926</pages><issn>1526-6028</issn><eissn>1545-1550</eissn><abstract>The purpose was to analyze the technical, clinical, and survival outcomes of our patients with malignant superior cava vein syndrome (SVCS) treated with endovascular approach and analyze the efficacy of different stent types used. It is an observational, retrospective, single-center study. From 2006 to 2023, 42 patients (32 male, 10 female, mean age 62 years, age range, 41-87 years) underwent percutaneous stent placement for malignant SVCS. One stainless steel stent (Wallstent) and 2 venous nitinol stent type (Sinus-XL, Venovo) were used. Follow-up mean was 276 days. A total of 53 stents were deployed. Clinical success was 97.6% in less 24 hours. Technical success was achieved in 97.6%. No complications were found except 1 patient died during the procedure due to stent migration and atrial dissociation (2.3%). Overall intraprocedural stent migration rate was 11.9% (18.8% stainless steel stent, 9.6% nitinol stent, p&gt;0.05). Overall survival rates were 87.8%, 41.99%, and 34.12%, and overall primary patency rates were 100%, 93.3%, 91.6% at 1, 6, and 12 months, respectively. Endovascular treatment is a safe and effective therapeutic option for SVCS with high technical and clinical success rates and low complication and recurrence rates. The malignant superior cava vein syndrome is a rare clinical entity treated classically with radiation and chemotherapy with a slower response, or surgical bypass, which is an aggressive surgical technique. Endovascular treatment offers a low-invasive technique with quick clinical resolution and good permeability results. However, further studies are lacking to deal with procedure technical characteristics, stent type used, technical complications, and medium- and long-term patency studies. This study aims to evaluate all these items, analysing self-expanding stainless steel and nitinol venous bare metal stents, and add value to endovascular treatment, confirming the good results of this technique.</abstract><cop>United States</cop><pmid>38676408</pmid><doi>10.1177/15266028241242926</doi><orcidid>https://orcid.org/0009-0001-0636-6156</orcidid><orcidid>https://orcid.org/0009-0001-1066-122X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1526-6028
ispartof Journal of endovascular therapy, 2024-04, p.15266028241242926-15266028241242926
issn 1526-6028
1545-1550
language eng
recordid cdi_proquest_miscellaneous_3047937589
source SAGE Complete A-Z List
title Results of Palliative Stenting in Malignant Superior Vena Cava Syndrome Analyzing Self-Expanding Stainless Steel and Nitinol Venous Bare Metal Stents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A43%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Results%20of%20Palliative%20Stenting%20in%20Malignant%20Superior%20Vena%20Cava%20Syndrome%20Analyzing%20Self-Expanding%20Stainless%20Steel%20and%20Nitinol%20Venous%20Bare%20Metal%20Stents&rft.jtitle=Journal%20of%20endovascular%20therapy&rft.au=Rioja%20Artal,%20Sara&rft.date=2024-04-27&rft.spage=15266028241242926&rft.epage=15266028241242926&rft.pages=15266028241242926-15266028241242926&rft.issn=1526-6028&rft.eissn=1545-1550&rft_id=info:doi/10.1177/15266028241242926&rft_dat=%3Cproquest_cross%3E3047937589%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3047937589&rft_id=info:pmid/38676408&rfr_iscdi=true